505 Results for "

CDC

" in MedChemExpress (MCE) Product Catalog:
Products (505)

505 Results for "CDC" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-N2438
CAS No.: 74805-91-7
Methylophiopogonanone B is a homoisoflavonoid compound. Methylophiopogonanone B can be isolated from O. japonicus root. Methylophiopogonanone B promotes Rho activation and Tubulin depolymerization. Methylophiopogonanone B significantly increases GTP-Rho, but not GTP-Rac or GTP-CDC42. Methylophiopogonanone B induces cell morphological change via melanocyte dendrite retraction and stress fiber formation. Methylophiopogonanone B exhibits strong antioxidant activity. Methylophiopogonanone B can be used in the research of cervical cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10943
CAS No.: 839706-07-9
Purity:  99.70%
Target:  

Bcr-Abl Ack1

Research Areas:  

Cancer

GNF-7 is a multikinase inhibitor. GNF-7 is a Bcr-Abl inhibitor, with IC50s of 133 nM and 61 nM for Bcr-Abl WT and Bcr-Abl T315I, respectively. GNF-7 also possesses inhibitory activity against both ACK1 (activated CDC42 kinase 1) and GCK (germinal center kinase) with IC50s of 25 nM and 8 nM, respectively. GNF-7 can be used for the research of hematologic malignancies .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N7045
CAS No.: 142796-22-3
Isosilybin B is a flavonolignan. Isosilybin B can be isolated from Silybum marianum. Isosilybin B can regulate cell cycle-related proteins (e.g., reduce cyclins (D3, D1, A, E), Cdk4, Cdk2, Cdc25A), and activate Caspases (Caspase-9 and Caspase-3). Isosilybin B can promote Apoptosis, reduce androgen receptor (AR) and PSA. Isosilybin B has anticancer activity against prostate cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-117049
CAS No.: 1112978-84-3
Purity:  98.70%
Leucettine L41 is a potent inhibitor of dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) and CDC-like kinases (CLKs). Leucettine L41 can also inhibit GSK-3 singnaling. Leucettine L41 can inhibit cell apoptosis and ROS production. Leucettine L41 can promote β-cell cell cycle progression, cell proliferation and increase insulin secretion. Leucettine L41 can be used for the researches of neurological disease and metabolic disease, such as Alzheimer’s disease (AD) and diabetes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101523
CAS No.: 1402055-25-7
Purity:  99.77%
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-1 (Compound 13) is a highly potent, selective and ATP competitive inhibitor of Cdc7 kinase, with an IC50 value of 0.6 nM at 1 mM ATP and with slow off-rate characteristics. Cdc7-IN-1 potently inhibits Cdc7 activity in cancer cells, and effectively induces cell death .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-126246
CAS No.: 2374831-10-2
Purity:  98.09%
Target:  

Phosphatase

Research Areas:  

Cancer

CDC25B-IN-1 (compound 4a) is a potent inhibitor of cell division cycle 25B (CDC25B) phosphatase, with a Ki of 8.5 μM. CDC25B-IN-1 potently inhibits cell proliferation and colony formation, causes an increase of the G2/M phase .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P9968
CAS No.: 780758-10-3
Synonyms: h-R3

Target:  

EGFR

Research Areas:  

Cancer

Nimotuzumab is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab is directed against the extracellular domain of the EGFR blocking the binding to its ligands. Nimotuzumab, a strong antitumor agent, is cytolytic on target tumors by its capacity to cause antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136383
CAS No.: 1071098-42-4
Purity:  98.07%
Synonyms: Rac1/CDC42-IN-1
Target:  

Ras Apoptosis

Research Areas:  

Cancer

AZA1 is a potent dual inhibitor of Rac1 and Cdc42. AZA1 induces prostate cancer cells apoptosis and inhibits prostate cancer cells proliferation, migration and invasion .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99117
CAS No.: 2394841-59-7
Synonyms: AK104

Target:  

PD-1/PD-L1 CTLA-4

Research Areas:  

Inflammation/Immunology Cancer

Cadonilimab (AK104) is a humanized tetravalent IgG1 bispecific antibody targeting PD1/CTLA4. Cadonilimab blocks both PD-1 and CTLA-4 pathways, thereby relieving their corresponding immunosuppressive effects and reversing tumor specific T cell exhaustion. Cadonilimab significantly downregulates Fc-mediated effector functions, including antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement dependent cytotoxicity (CDC). Cadonilimab can be used for research of metastatic cervical cancer, as well as other malignancies such as gastric cancer, GEJ adenocarcinoma and non-small cell lung cancer (NSCLC) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112776A
CAS No.: 1049740-43-3
Purity:  99.36%
Target:  

Phosphatase

Research Areas:  

Cancer

BN82002 hydrochloride is a potent, selective and irreversible inhibitor of CDC25 phosphatase family. BN82002 hydrochloride inhibits CDC25A, CDC25B2, CDC25B3, CDC25C CDC25A, and 25C-cat with IC50 values of 2.4, 3.9, 6.3, 5.4, and 4.6 µM, respectively. BN82002 hydrochloride displays ~20-fold greater selectivity over CD45 tyrosine phosphatase .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-170327
CAS No.: 664975-73-9
Target:  

Ras

Research Areas:  

Cancer

ZCL279 is a small molecule modulator (SMM) that inhibits Cdc42-intersectin (ITSN) interaction. ZCL279 can activate Cdc42 (a cytoplasmic small GTPase in the Ras superfamily) at lower concentrations (<10 μM) and significantly inhibit it at higher concentrations (<10 μM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-139301
CAS No.: 2355377-13-6
Purity:  99.20%
Target:  

HSP

Research Areas:  

Cancer

DDO-5936 is a potent and specific Hsp90-Cdc37 PPI inhibitor. DDO-5936 can be used for the research of colorectal cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-139606
CAS No.: 2630950-38-6
Target:  

p97

Research Areas:  

Cancer

VCP/p97 inhibitor-1 is a potent inhibitor of VCP/p97 (also called Cdc48, CDC-. 48, or Ter94) with an IC50 of 54.7 nM. VCP/p97 inhibitor-1 causes the dysregulation of protein homeostasis and disturbs the degradation of misfolded polypeptides by the ubiquitin-proteasome system (UPS) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12828
CAS No.: 1354037-26-5
Purity:  98.03%
Target:  

CDK

Research Areas:  

Infection Neurological Disease

KH-CB19 is a potent CLK (cdc2-like kinase) inhibitor (CLK1 IC50=19.7 nM; CLK3 IC50=530 nM). KH-CB19 shows antiviral activity and inhibits influenza virus replication (IC50=13.6?μM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80076
Synonyms: CDC2 related protein kinase; CDC28; CDC2A; Cdk 2; CDK1; CDK2; CDK2_HUMAN ; CDKN2; MPF; p33(CDK2) antibody;

Host:  

Rabbit

Application:  

WB, ICC/IF, IHC-P, IP, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-130257
CAS No.: 2509359-75-3
Purity:  99.31%
Target:  

PROTACs APC Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

CP5V is a Cdc20 PROTAC degrader with a DC50 of 1.6 μM and a Kd value of 12.4 μM. CP5V couples Cdc20 with the VHL/VBC complex, triggering its ubiquitination and proteasomal degradation, thereby reducing the protein levels of Cdc20 and securin. CP5V induces mitotic arrest, inhibits cell proliferation, resensitizes Paclitaxel-resistant breast cancer cells, and suppresses breast tumor progression in xenograft models. CP5V inhibits excessive proliferation and induces apoptosis in pulmonary arterial hypertension smooth muscle cells and fibroblasts. CP5V can be used in studies related to breast cancer and pulmonary arterial hypertension .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N6742
CAS No.: 7184-60-3
Synonyms: Treponemycin
Borrelidin (Treponemycin) is a bacterial and eukaryal threonyl-tRNA synthetase inhibitor which is a nitrile-containing macrolide antibiotic isolated from Streptomyces rochei . Borrelidin is an inhibitor of Cdc28/Cln2 of the budding yeast, with an IC50 of 24 μM . Borrelidin is a potent angiogenesis inhibitor, with an IC50 of 0.8 nM. Borrelidin induces apoptosis in the tube-forming cells . Borrelidin has strong antimalarial activities, with IC50s of 1.9 nM and 1.8 nM against K1 and FCR3 strains of Plasmodium falciparum, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108709
CAS No.: 1618658-88-0
Purity:  99.06%
Target:  

CDK

Research Areas:  

Cancer

CC-671 is a dual TTK protein kinase/CDC2-like kinase (CLK2) inhibitor with IC50s of 0.005 and 0.006 μM for TTK and CLK2, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13255
CAS No.: 901-47-3
Purity:  99.51%
Target:  

APC

Research Areas:  

Cancer

TAME is an inhibitor of anaphase-promoting complex/cyclosome (APC/C or APC), which binds to APC/C and prevents its activation by Cdc20 and Cdh1, produces mitotic arrest. TAME is not cell permeable .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13255A
CAS No.: 1784-03-8
Purity:  98.31%
Target:  

APC

Research Areas:  

Cancer

TAME hydrochloride is an inhibitor of anaphase-promoting complex/cyclosome (APC/C or APC), which binds to APC/C and prevents its activation by Cdc20 and Cdh1, produces mitotic arrest. TAME hydrochloride is not cell permeable .
loading...
    loading...